...
首页> 外文期刊>Biochemistry >Molecular Cloning of the Human Platelet-Derived Growth Factor Receptor β (PDGFR-β) Promoter and Drug Targeting of the G-Quadruplex-Forming Region To Repress PDGFR-β Expression
【24h】

Molecular Cloning of the Human Platelet-Derived Growth Factor Receptor β (PDGFR-β) Promoter and Drug Targeting of the G-Quadruplex-Forming Region To Repress PDGFR-β Expression

机译:人血小板衍生生长因子受体β(PDGFR-β)启动子的分子克隆和G-四链体形成区的药物靶向以抑制PDGFR-β表达

获取原文
获取原文并翻译 | 示例
           

摘要

To understand the mechanisms controlling platelet-derived growth factor receptor β (PDGFR-β)nexpression in malignancies, we have cloned and characterized the first functional promoter of the humannPDGFR-β gene, which has been confirmed by luciferase reporter gene assays. The transcription initiationnsites were mapped by primer extension. Promoter deletion experiments demonstrate that the proximal, highlynGC-rich region (positions -165 to -139) of the human PDGFR-β promoter is crucial for basal promoternactivity. This region is sensitive to S1 nuclease and likely to assume a non-B-form DNA secondary structurenwithin the supercoiled plasmid. The G-rich strand in this region contains a series of runs of three or morenguanines that can formmultiple differentG-quadruplex structures, which have been subsequently assessed byncircular dichroism. A Taq polymerase stop assay has shown that three different G-quadruplex-interactivendrugs can each selectively stabilize different G-quadruplex structures of the human PDGFR-β promoter.nHowever, in transfection experiments, only telomestatin significantly reduced the human PDGFR-β basalnpromoter activity relative to the control. Furthermore, the PDGFR-β mRNA level in Daoy cells wasnsignificantly decreased after treatment with 1 μM telomestatin for 24 h. Therefore, we propose that ligand-nmediated stabilization of specific G-quadruplex structures in the human PDGFR-β promoter can modulatenits transcription.
机译:为了了解在恶性肿瘤中控制血小板衍生的生长因子受体β(PDGFR-β)的表达的机制,我们已经克隆和鉴定了人类PDGFR-β基因的第一个功能启动子,这已经通过萤光素酶报告基因检测得到了证实。通过引物延伸来定位转录起始位点。启动子缺失实验表明,人PDGFR-β启动子的近端高度富含GC的区域(-165至-139位)对于基础启动子活性至关重要。该区域对S1核酸酶敏感,并且可能在超螺旋质粒内假定为非B型DNA二级结构。该区域中富含G的链包含一系列的三个或多个鸟嘌呤,这些鸟嘌呤可形成多个不同的G-四链体结构,随后通过圆二色性对其进行了评估。 Taq聚合酶终止试验表明,三种不同的G-四链体相互作用药物可以选择性地稳定人PDGFR-β启动子的不同G-四链体结构。然而,在转染实验中,只有端粒他汀能显着降低人PDGFR-βbasalnpromoter相对活性。到控制。此外,用1μMtelomestatin处理24 h后,Daoy细胞中的PDGFR-βmRNA水平显着降低。因此,我们提出人类PDGFR-β启动子中特定G-四链体结构的配体介导的稳定化可以调节转录。

著录项

  • 来源
    《Biochemistry》 |2010年第19期|p.4208-4219|共12页
  • 作者单位

    ‡College of Pharmacy, 1703 East Mabel, University of Arizona, Tucson, Arizona 85721,§Arizona Cancer Center, 1515 NorthCampbell Avenue, Tucson, Arizona 85724,) BIO5 Collaborative Research Institute, 1657 East Helen Street, Tucson,Arizona 85721, and ^Department of Chemistry, University of Arizona, Tucson, Arizona 85721;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号